Onward Assist
Founded Year
2017Stage
Incubator/Accelerator - IV | AliveTotal Raised
$80KAbout Onward Assist
Onward Assist uses machine learning and artificial intelligence to analyze, diagnose and predict the behavior of cancer cells in patients. It combines a computer-based algorithm that allows oncopathologists to gain insights into the tumor and the neighboring tissue and ensure accurate prognosis and treatment protocols. The company was founded in 2017 and is based in Hyderabad, India.
- Predict emerging trends
- See competitors' playbooks
- Stalk the smart money
- Identify tomorrow's challengers
- Spot growing industries
- Kill analyst data work
Onward Assist's Product Videos
Onward Assist's Products & Differentiators
PathFlow Dx
Digital Pathology viewer and workflow manaement software that helps pathologists and labs transition seamlessly to digital workflow
Expert Collections containing Onward Assist
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Onward Assist is included in 3 Expert Collections, including Artificial Intelligence.
Artificial Intelligence
10,944 items
Companies developing artificial intelligence solutions, including cross-industry applications, industry-specific products, and AI infrastructure solutions.
Digital Health
10,563 items
The digital health collection includes vendors developing software, platforms, sensor & robotic hardware, health data infrastructure, and tech-enabled services in healthcare. The list excludes pureplay pharma/biopharma, sequencing instruments, gene editing, and assistive tech.
Oncology Tech
457 items
This collection includes companies applying technology to cancer care, diagnosis, and treatment. Examples include vendors offering cancer detection and diagnosis, oncology clinical decision support, real-world data, and AI oncology drug discovery.
Latest Onward Assist News
Jan 10, 2022
The seven healthcare startups -- MedPiper Technologies, Dial4242 Ambulance Services, Dockare, Daffodil Health, Onward Assist, MayaMD and NeuroLeap -- are currently undergoing a 9-month incubation programme NSRCEL, the startup hub at IIM Bangalore, on Monday said it has selected seven early-stage healthcare startups for the final stage of the incubation programme to start their "lab to market" journey. Source: Website NSRCEL, the startup hub at IIM Bangalore, on Monday said it has selected seven early-stage healthcare startups for the final stage of the incubation programme to start their "lab to market" journey. The seven healthcare startups -- MedPiper Technologies, Dial4242 Ambulance Services, Dockare, Daffodil Health, Onward Assist, MayaMD and NeuroLeap -- are currently undergoing a 9-month incubation programme. See Zee Business Live TV Streaming Below: The programme is designed to support MVP (minimum viable product) to commercialisation stage ventures that have the potential to increase access and affordability of healthcare in India, NSRCEL said in a statement. Commenting on the development, Anand Sri Ganesh, COO, NSRCEL at IIM Bangalore said, "The COVID-19 outbreak was a huge wakeup call for the Indian healthcare system, and emphasised the role of innovation to make healthcare available, accessible and affordable for the masses. As the first program at NSRCEL focused on a healthcare venture, we are excited to see the impact they create". NSRCEL said its structured incubation programme provides support to healthcare innovators and entrepreneurs through their 'lab to market' journey. With the NSRCEL healthcare incubation programme, both clinicians and hospitals can engage with startups and mentor and monitor the progress of those startups, which can contribute to their strategic objectives, it added. "This is a first of its kind incubation program wherein the clinicians, technology, business, and healthcare industry experts together are nurturing the ventures for the first time in India in a big way," Prashanth R Reddy, Program Advisor Healthcare Incubation NSRCEL at IIM-Bangalore, said. The ventures selected in this cohort are working in areas like oncology, neurology, mental health and HR tech for doctors, among others. They will be engaged in domain-specific support through mentors, industry experts, and investors in the healthcare space during their incubation journey, NSRCEL said, adding it would facilitate networking and peer-learning sessions to explore synergies within and beyond the NSRCEL startup ecosystem.
Onward Assist Frequently Asked Questions (FAQ)
When was Onward Assist founded?
Onward Assist was founded in 2017.
Where is Onward Assist's headquarters?
Onward Assist's headquarters is located at CIE, IIITH Campus, Gachibowli, Hyderabad.
What is Onward Assist's latest funding round?
Onward Assist's latest funding round is Incubator/Accelerator - IV.
How much did Onward Assist raise?
Onward Assist raised a total of $80K.
Who are the investors of Onward Assist?
Investors of Onward Assist include NSRCEL Healthcare Program, India Edison Accelerator, Nasscom DeepTech Club, Microsoft for Startups, The Centre for Innovation and Entrepreneurship and 3 more.
Who are Onward Assist's competitors?
Competitors of Onward Assist include Ibex and 2 more.
What products does Onward Assist offer?
Onward Assist's products include PathFlow Dx and 1 more.
Who are Onward Assist's customers?
Customers of Onward Assist include Krsnaa Diagnostics and Sandor Medicaids.
- Predict emerging trends
- See competitors' playbooks
- Stalk the smart money
- Identify tomorrow's challengers
- Spot growing industries
- Kill analyst data work
Compare Onward Assist to Competitors
Mindpeak automates microscopical and pathological analysis with artificial intelligence and deep learning.
Aiosyn is a medical software company that develops AI-powered pathology solutions. It develops computational pathology technology to facilitate decision-making in both drug development and clinical diagnostics. The company provides perspectives that lead to patient identification and stratification in drug development programs. It provides solutions for biotech, pharma, and diagnostics companies. Aiosyn was founded in 2021 and is based in Nijmegen, Netherlands.
Qritive develops diagnostic tools. It integrates artificial intelligence and helps clinicians examine microscopy images and text from patient data. It allows medical practitioners to identify cancer quickly with the help of natural language processing. It develops Pantheon an artificial intelligence (AI)-driven ecosystem transforming pathology. The company was founded in 2017 and is based in Singapore, Singapore.
Stratipath focuses on individualized medicine through AI-based precision diagnostics for cancer.
Mechanomind is an artificial intelligence (AI) image recognition for cancer diagnostics. It applies computer vision and deep learning to solve the problem of accessibility, accuracy, speed, and cost of cancer diagnostics worldwide. The company was founded in 2015 and is based in New York, New York.
PathAI provides artificial intelligence (AI)-powered research tools and services for pathology. It delivers diagnosis and treatment of cancer leveraging modern approaches in machine learning. It offers biopharma lab services, clinical development services, drug and diagnostic development, and more. The company was founded in 2016 and is based in Boston, Massachusetts.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.
